Insulin Aspart Injection, Solution
Product Images NDC 50090-4956

Product Visual Gallery

This gallery contains 45 technical images submitted to the FDA as part of the official labeling for Insulin Aspart (NDC 50090-4956). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by A-s Medication Solutions, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Molecular Formula (Image 01)

Chemical structure diagram depicting the amino acid sequence and disulfide bonds of insulin aspart, showing its A-chain and B-chain with labeled amino acids and their positions.*

FDA Label Image

Figure 1 (Image 02)

A line graph depicting serum glucose levels (mg/dL) over time (hours) with two distinct curves, one dashed and one solid, illustrating changes in glucose concentration during a 6-hour period.*

FDA Label Image

Figure 3 (Image 03)

A line graph depicting mean blood glucose levels (mg/dL) over time (minutes) with a time axis marked from 0 to R+60 minutes and a vertical reference point at R. The graph shows changes in glucose levels before and after the reference time, with error bars indicating variability at each time point.*

FDA Label Image

Figure 4 (Image 04)

A line graph showing free serum insulin levels (mU/L) over time (hours). The graph includes two curves measuring insulin concentration changes from 0 to 6 hours. The solid line peaks sharply around 1 hour and then declines, while the dashed line rises more gradually, plateaus, and slowly decreases over time.*

FDA Label Image

Overview (FlexPen)

An instructional diagram of the Insulin Aspart FlexPen showing its main parts, including the pen cap, rubber stopper, cartridge, cartridge scale, dose pointer, dose selector, and push-button, illustrating the pen's components for insulin injection delivery.*

FDA Label Image

Novifine And Novofine Plus (Overview)

An instructional illustration comparing components of NovoFine and NovoFine Plus insulin needle caps. It shows labeled parts including the big outer needle cap, inner needle cap, needle, and protective tab for each needle type.*

FDA Label Image

Vial Figure (Image 07)

An illustration of a vial for insulin aspart injection, showing a tamper-resistant cap and a rubber stopper underneath the cap. The vial is depicted in a simple line drawing style.*

FDA Label Image

Hand And Vial Figure (Image 08)

An instructional illustration showing a hand holding a small glass vial upright, typically used for injection solutions. The image highlights the proper way to hold the vial for administration or preparation of the medication.*

FDA Label Image

Figure A And Figure B (Image 09)

An instructional illustration showing two sequential steps (Figure A and Figure B) of opening a vial by twisting the top cap with fingers. The images demonstrate hand actions on a small bottle, likely related to preparing an injection solution such as insulin aspart.*

FDA Label Image

Figure C (Image 10)

An instructional illustration showing how to prepare an injection. It depicts one hand holding a syringe with the needle pointing down into a vial held by the other hand, with a downward arrow indicating the direction of needle insertion into the vial. A close-up inset shows the syringe barrel with graduations visible.*

FDA Label Image

Figure D (Image 11)

Illustration labeled Figure D showing a person holding a syringe in one hand and a vial in the other, demonstrating how to draw insulin aspart solution from the vial into the syringe.*

FDA Label Image

Figure E (Image 12)

An instructional illustration showing a hand inserting a needle into a vial with a downward arrow indicating the direction of insertion, labeled as Figure E. This likely demonstrates part of the preparation or administration process for an injectable solution.*

FDA Label Image

Figure F (Image 13)

An instructional illustration showing a hand holding a vial upside down with a syringe below it. An arrow points downward indicating the direction to draw liquid from the vial into the syringe. This image likely demonstrates how to prepare an injection of insulin aspart.*

FDA Label Image

Figure G (Image 14)

An instructional illustration labeled 'Figure G' showing a pair of hands preparing an injection. One hand holds a vial upside down while withdrawing liquid with a syringe held in the other hand, demonstrating proper technique for drawing medication into a syringe.*

FDA Label Image

Figure H (Image 15)

Instructional illustration showing the preparation of an insulin aspart injection solution. It depicts a hand holding a vial upside down and using a syringe to draw the solution, highlighting the correct method for subcutaneous or intravenous administration preparation.*

FDA Label Image

Figure I (Image 16)

An instructional illustration showing a hand holding a syringe and another hand holding a vial with the vial's cap being removed. This image likely demonstrates the initial step of preparing a medication injection.*

FDA Label Image

Fig. J (Image 17)

Illustration showing the recommended injection sites for Insulin Aspart, including the abdomen, upper outer thigh, and upper buttocks areas on a front and back view of a human body outline.*

FDA Label Image

Figure K (Image 18)

An instructional illustration labeled as Figure K showing a person's hands drawing insulin into a syringe from a vial. One hand holds the vial upside down while the other pulls the syringe plunger to fill it with solution.*

FDA Label Image

Figure L (Image 19)

An instructional illustration labeled "Figure L" showing a hand administering an injection into the skin of an arm using a syringe. The image depicts subcutaneous injection technique for a solution dosage form.*

FDA Label Image

Novotwist Needle (Image 20)

An illustration labeled 'NovoTwist' showing four components of an injection device: a big outer needle cap, an inner needle cap, a needle, and a protective tab. Each part is visually separated and labeled above the corresponding image.*

FDA Label Image

Pull Off The Pen Cap (Image 21)

An instructional illustration showing a hand removing a cap from a vial or syringe by pulling it upward. The image appears to demonstrate the first step in preparing an injection, relevant for products like Insulin Aspart injection solution.*

FDA Label Image

Turn The Dose Selector To Select 2 Units. (Image 22)

An instructional illustration showing hands adjusting a dial on an injection pen to select a dose. The indication highlights that 2 units are selected, demonstrated by a close-up view of the dosage window on the pen. The image relates to dose setting for insulin aspart injection, solution.*

FDA Label Image

Tap The Cartridge Gently (Image 23)

An instructional illustration showing a hand pressing the plunger of a syringe, depicted next to a forearm. The image suggests the action of injecting a medication, relevant to subcutaneous or intravenous injection technique.*

FDA Label Image

Keep The Needle Pointing Upwards (Image 24)

Illustration showing a hand holding and pressing the top of an insulin pen injector, with an arrow indicating an upward motion. A smaller inset image shows a close-up of the needle attached to the pen, highlighting the injection mechanism likely related to insulin aspart injection use.*

FDA Label Image

Turn The Dose Selector To The Number Of Units You Need To Inject (Image 25)

An instructional illustration showing a close-up of a hand adjusting a dose selector on a pen-style injector device. The dial displays selections of 5 units and 24 units, demonstrating the mechanism for setting the injection dose for Insulin Aspart 100 units/mL solution by A-S Medication Solutions.*

FDA Label Image

Giving The Injection (Image 26)

An instructional illustration showing a hand holding a vial or container, with an arrow indicating downward pressure or direction, possibly demonstrating how to open or use the product. The vial has visible markings or labels but the text is not fully legible.*

FDA Label Image

Making Sure That The Full Dose Has Been Given (Image 27)

An instructional illustration showing a syringe needle positioned just above the skin surface, demonstrating the technique for subcutaneous or intravenous injection of insulin aspart solution.*

FDA Label Image

Put The Pen Cap On (Image 28)

An instructional illustration depicting a hand holding an insulin pen and removing the cap by pulling it straight off. The image is part of usage instructions for insulin delivery devices.*

FDA Label Image

Figure A Penfill Cartridge And Needle Components. (Image 41)

Illustration showing components of NovoFine, NovoFine Plus, and NovoTwist needles including outer needle cap, inner needle cap, needle, and paper tab. It also depicts a PenFill cartridge insulin delivery device with labeled parts: pen cap, cartridge holder, cartridge 3 mL example, threaded end for needle attachment, colored band, rubber plunger, dose pointer, dose counter, and dose selector/dose button.*

FDA Label Image

Diagram B: Attaching The Needle. (Image 43)

An instructional illustration showing how to attach a NovoFine or Novo Fine Plus needle to a Novo Twist syringe for insulin injection. The image depicts hands rotating and aligning the needle for proper attachment.*

FDA Label Image

Diagram C: Pull Off The Outer Needle Cap. (Image 44)

An instructional illustration showing how to attach a needle to NovoFine or NovoFine Plus, and to NovoTwist syringe tips used for insulin aspart injection. The two-step images guide the user to properly connect the needle by aligning and pushing it onto the syringe tip.*

FDA Label Image

Diagram D: Pull Off Inner Needle Cap. (Image 45)

An instructional illustration comparing two types of devices labeled NovoFine and NovoFine Plus, and NovoTwist. The image shows hand positioning and the attachment or removal of a needle cap on an injection device, with directional arrows indicating motion for each device.*

FDA Label Image

Figure B: Check The Penfill Cartridge. (Image 53)

An instructional illustration showing a hand holding a syringe with a threaded end. The image highlights the threaded end of the syringe, suggesting a focus on proper assembly or connection of the syringe components.*

FDA Label Image

Figure C: Insert The Cartridge. (Image 58)

An instructional illustration showing the attachment of a syringe needle to a cartridge or pen device. The image depicts hands holding the syringe and cartridge with an arrow indicating the direction to connect the syringe needle into the cartridge or pen.*

FDA Label Image

Figure D: Pust The Needle Straight On. (Image 59)

An instructional illustration showing two types of insulin delivery devices labeled 'NovoFine' and 'NovoFine Plus' on the left and 'NovoTwist' on the right. The diagrams depict how to attach or remove needles, indicating finger and hand positions for using these NovoFine needles with insulin injection devices.*

FDA Label Image

Figure E: Pull Off The Outer Needle Cap. (Image 60)

An instructional illustration showing how to attach pen needle devices named NovoFine and NovoTwist. It depicts hands holding the pen needles and an arrow indicating rotational movement for attachment, highlighting proper use techniques.*

FDA Label Image

Figure F: Pull Off The Inner Needle Cap. (Image 61)

An instructional diagram comparing the connection method of a NovoFine or NovoFine Plus needle to a syringe versus a NovoTwist needle system for injection. It visually shows the step of attaching the needle with arrows indicating the direction of connection.*

FDA Label Image

Figure I: Injection Sites (Image 62)

An instructional diagram showing recommended injection sites for insulin aspart injection solution. The diagram highlights four areas on a human figure: upper arms, abdomen, upper thighs, and buttocks. Each area is labeled for clear identification as suitable places to inject the medication.*

FDA Label Image

Figure J: Count Slowly. (Image 63)

An instructional illustration showing a hand holding an insulin injection pen inserted into the arm. A speech bubble indicates to count slowly from 1 to 6 during the injection. This diagram guides proper insulin aspart injection technique preparation.*

FDA Label Image

Figure K: Lead The Needle Tip Into The Outer Cap. (Image 65)

An instructional diagram showing how to attach a needle to a syringe or pen injector. The image depicts a needle cap being aligned to connect with the device, indicated by two blue arrows showing the direction for attaching the components.*

FDA Label Image

Figure L: Unscrew The Needle. (Image 66)

An instructional illustration showing hands holding an insulin cartridge and turning the cartridge holder to unscrew or remove it. The image visually guides the user on handling the cartridge holder component of an insulin injection device.*

FDA Label Image

Figure M: Put The Cap On The Device. (Image 67)

An instructional illustration showing a hand holding a syringe with a vial or pen device and an arrow pointing downward, indicating the step of drawing or preparing insulin aspart injection solution for use.*

FDA Label Image

Figure G: Insulin Squirts. (Image 68)

Insulin Aspart 100 IU/mL injection solution vial for intravenous and subcutaneous use. The image shows a vial with an attached needle or tubing extension. The product is labeled by A-S Medication Solutions.*

FDA Label Image

Figure H: Select Your Dose. (Image 69)

An instructional illustration showing a close-up of a dose selector on a device for insulin aspart injection solution. It demonstrates how to set the dose by turning the dose selector to the desired units indicated by the dose pointer, with an example selection of 12 units.*

FDA Label Image

Label Image (Lbl500904956)

Insulin Aspart FlexPen Injection 100 units/mL label from A-S Medication Solutions. The label states each milliliter contains 100 units of insulin aspart and is supplied as 5 prefilled insulin syringes. Storage instructions include refrigeration at 36 to 46 degrees Fahrenheit until first use and protection from light. The label shows the product NDC 50090-4956-0 and lot number information.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.